Development and validation of a potency assay matrix for optimized and consistent manufacture of clinical mesenchymal stem/stromal cells
IntroductionMesenchymal stem/stromal cells (MSCs) are being evaluated as cell-based therapies for inflammatory and immune-mediated disorders. However, variability in clinical efficacy and a lack of validated potency assays have impeded regulatory appro…